Ambys Medicines

Ambys Medicines

Ambys Medicines

Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases.
Raised
$200M
Follow us
Alexa global traffic share
Latest funding
$60,000,000
Venture capital (Series A) - 2018
Third Rock Ventures Takeda Ventures
$140,000,000
Venture capital (Series A) - 2018
Third Rock Ventures Takeda
Team Size
1–10
Employees
$140,000,000 Venture capital (Series A)
FinSMEs

Ambys Medicines Launches with $140M in Funding

Health Science Funding